Results 61 to 70 of about 24,852 (213)
, 2021 Supplementary Figure. Clinical features of mycosis fungoides with head and neck involvement at diagnosis Tumor stage mycosis fungoides in a 42-year-old male patient (A) and folliculotropic mycosis fungoides in a 53-year-old male patient (B)
Lee, W
core +2 more sources
The different face of skin‐rash induced by brentuximab vedotin
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri +11 more
wiley +1 more source
Acta Dermato-Venereologica, 2021 Low-dose methotrexate is widely used in mycosis fungoides and Sézary syndrome, but few studies have evaluated this treatment. The aim of this study was to evaluate the benefit/risk ratio of this regimen on skin lesions. A retrospective survey of a series
Fawaz Alenezi +5 more
doaj +1 more source
Diagnostic Accuracy of Dermoscopy and Trichoscopy in Mycosis Fungoides. A Systematic Review
Mycosis fungoides is the most common cutaneous T-cell lymphoma. The aim of this review is to assess the value of dermoscopy and trichoscopy in mycosis fungoides diagnosis.
Agnieszka Michalczyk +6 more
core +1 more source
Mycosis Fungoides: A Case Report [PDF]
, 2021 Mycosis fungoides is the most common primary cutaneous T-cell lymphoma and is recognized as one of the rare malignant skin neoplasms. Hypopigmented mycosis fungoides is a variant of mycosis fungoides, described in dark-skinned individual and Asian ...
Anisha Joshi, Deeptara Pathak Thapa
core
Acta Dermato-Venereologica, 2017 The aim of this 10-year monocentric prospective study was to determine a cut-off value of Fas/CD95 expression by peripheral blood CD4+ T lymphocytes in discriminating patients with mycosis fungoides from controls with cutaneous benign lymphocytic ...
Aurélie Du-Thanh +5 more
doaj +1 more source
Ropeginterferon‐α2b in mycosis fungoides and Sézary syndrome: Safety and efficacy in 41 patients
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Background and objectives Pegylated interferon‐α2a became the off‐label alternative for treating mycosis fungoides/Sézary syndrome (MF/SS) after non‐pegylated interferons were withdrawn. This study aimed to evaluate the safety and efficacy of ropeginterferon‐α2b in MF/SS. Patients and methods We performed a retrospective multicenter analysis at
Stefanie Porkert +15 more
wiley +1 more source
Mycosis Fungoides: Tumour d′emblee
, 2012 Mycosis Fungoides is a Cutaneous T-cell lymphoma characterized by infiltration of skin with patches, plaques, and nodules composed of T-lymphocytes.
Syed Mubashir +6 more
core +1 more source
A verrucous presentation of mycosis fungoides [PDF]
, 2014 Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma and can have a variety of clinical and histological manifestations, including erythrodermic, pustular, bullous, hypo/hyperpigmented, and verrucous forms.
Bunata, Kristin +8 more
core +1 more source
Increased Expression of Delta-like Ligand 4 in Mycosis Fungoides
Acta Dermato-Venereologica, 2020 In many malignancies, dysregulation of the Notch pathways, composed of 4 Notch receptors (Notch1–4) and 5 Notch ligands (Jagged1–2, Delta-like ligand-1, 3–4), is associated with their development.
Hikari Boki +8 more
doaj +1 more source